Pro 2013-001 (Announcement on Resolution of 8th Board of Directors of Jianfeng Group)
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Lin 2013-001
Zhejiang Jianfeng Group Co., Ltd.
Resolution Announcement of the 8th Meeting of the 8th Board of Directors
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .
On December 20, 2012, Zhejiang Jianfeng Group Co., Ltd. issued a notice to convene the eighth meeting of the eighth board of directors by fax, e-mail, telephone, and personal delivery. On December 31, 2012, the meeting was held as scheduled by means of communication. The company currently has nine directors, and nine directors participating in the voting , comply with the provisions of the "Company Law" and the "Articles of Association", and the resolutions made are legal and valid. The meeting passed the following resolutions:
1. the "Proposal on the Company's Compliance with the Conditions for Issuing Corporate Bonds"
According to the "the People's Republic of China Company Law", "the People's Republic of China Securities Law", "Corporate Bond Issuance Pilot Measures" And other relevant regulations, in accordance with the conditions for listed companies to issue corporate bonds, the company meets the conditions and requirements stipulated by the current policies and laws and regulations for issuing corporate bonds, eligible to issue corporate bonds.
Voting result :__9__ votes yes, __0__ votes no, __0__ votes abstaining.
This proposal shall be submitted to the general meeting of shareholders of the company for deliberation and voting.
2. "Proposal on Issuing Corporate Bonds";
Meeting deliberated and approved item by item: 1 , issuance scale ; 2 , allotment arrangement to the original shareholders of the company ; 3 , bond term ; 4 , bond interest rate and determination method ; 5 , issuance method ; 6 , issuance object ; 7 , guarantee arrangement; 8 , use of raised funds ; 9 , listing of issued bonds ; 10 , Effective date of resolution . For details, please refer to the "Announcement on the Issuance of Corporate Bonds" published on the same day. At the meeting of
, there were 82 votes , results were all :__9__ votes in favor, __0__ votes against, and __0__ votes abstained.
The above proposals still need to be submitted to the general meeting of shareholders for deliberation and submitted to the China Securities Regulatory Commission for approval.3. "Proposal on requesting the company's general meeting of shareholders to authorize the board of directors
and its authorized person to handle matters related to the issuance of corporate bonds"
According to the company's current corporate bond issuance and listing Arrangements, in order to complete the relevant work of this corporate bond legally, efficiently and orderly, in accordance with the "the People's Republic of China Company Law", "the People's Republic of China Securities Law", "Corporate Bond Issuance Pilot Measures" and other laws and regulations and the relevant provisions of the "Articles of Association of Zhejiang Jianfeng Group Co., Ltd.", the company's board of directors intends to request the company's general meeting of shareholders to authorize the board of directors to handle All matters related to the issuance of corporate bonds, the specific content includes but is not limited to:
1, within the scope permitted by laws and regulations, according to the specific conditions of the company and the market, formulate the specific issuance plan of this issue of corporate bonds and revise and adjust the issuance terms of this issue of corporate bonds, including but not limited to the specific issuance scale, bond term, bond interest rate and determination method, issuance timing, whether to issue in installments and the number of issues and the issuance scale of each issue, online and offline issuance ratio, whether to design the resale clause and redemption clause, whether to provide guarantee and guarantee method, the time limit and method of repayment of principal and interest, whether to allocate to shareholders and the specific arrangement of placing to shareholders, listing place and decision to raise funds the specific use of all matters relating to the issuance of the Company's bonds;
2, decide and hire intermediaries to participate in this corporate bond issuance;
3, select bond trustee, sign "bond trustee management agreement" and formulate "bondholder meeting rules";
4, handle the declaration of this corporate bond issuance, and after the completion of this issuance, to handle the listing of the bonds issued, including but not limited to formulation, approval, authorization, signing, execution, modification and completion of all necessary documents related to the issuance and listing of corporate bonds, contract / agreement, contract ( includes but not limited to prospectus, sponsorship agreement, underwriting agreement, bond trusteeship agreement, listing agreement, various announcements and other legal documents ) and appropriate information disclosure in accordance with laws, regulations and other regulatory documents;
5, request the general meeting of shareholders to authorize the board of directors to decide the amount of funds raised to repay company debt and supplement working capital according to the company's financial situation.
6. If the regulatory authority's policy on the issuance of corporate bonds changes or market conditions change, except for matters involving relevant laws, regulations and the company's articles of association that must be re-voted by the general meeting of shareholders, Authorize the board of directors to make corresponding adjustments to the specific corporate bond issuance plan and other related matters based on the new policies and opinions of the regulatory authority or new market conditions;
7. When the market environment or policies and regulations undergo major changes, the board of directors is authorized to decide whether to continue the corporate bond issuance based on the actual situation.
8, handle all other necessary matters related to the issuance of corporate bonds and listing.
. This authorization shall be from the date of deliberation and approval by the general meeting of shareholders to the date of completion of the above authorization.
The board of directors of the company intends to authorize the chairman and the secretary of the board of directors to handle specific matters related to this issuance in accordance with the scope of authorization of the general meeting of shareholders.
voting result :__9__ votes in favor, __0__ votes against, __0__ abstentions.
This proposal still needs to be reviewed and approved by the company's shareholders' meeting.
4. "Proposal on Requiring the General Meeting of Shareholders of the Company to Authorize the Board of Directors to Take Repayment Safeguard Measures in Case of Expected Failure to Pay Bond Principal and Interest on Time or Failure to Pay Bond Principal and Interest on Time"
The Company Requested the General Meeting of Shareholders to Authorize the Board of Directors to Make the following Resolutions and Take Corresponding Measures :
1 , no distribution of profits to shareholders;
2 , suspending the implementation of capital expenditure projects such as major foreign investment, mergers and acquisitions;
3 , reduce or suspend the salaries and bonuses of directors and senior management personnel;
4 , the main responsible person shall not be transferred.
voting result :__9__ votes in favor, __0__ votes against, __0__ abstentions.
This proposal still needs to be reviewed and approved by the company's shareholders' meeting.
Proposal of 5. on Convening the First Extraordinary General Meeting of Shareholders in 2013
Decided to Convene the First Extraordinary General Meeting of Shareholders in 2013 on 1 March 22 (Tuesday) in 2013 , for details, please refer to the "Notice on Convening the First Extraordinary General Meeting of Shareholders in 2013 " published on the same day.
voting result :__9__ votes in favor, __0__ votes against, __0__ abstentions.
hereby announce
Zhejiang Jianfeng Group Co., Ltd. Board of Directors
December 31, 2012
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page